Lantern Pharma Presents Positive Data on the Effectiveness of LP-284 in Hematologic Cancers at the 63rd American Society of Hematology (ASH) Annual Meeting
Go back to Lantern Pharma Presents Positive Data on the Effectiveness of LP-284 in Hematologic Cancers at the 63rd American Society of Hematology (ASH) Annual Meeting| (NASDAQ: LTRN) | Delayed: 2.07 -0.09 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.16 | 52 Week High | $ | |||
| Open | $2.17 | 52 Week Low | $ | |||
| Day High | $2.19 | P/E | N/A | |||
| Day Low | $2.07 | EPS | $ | |||
| Volume | 91,743 | |||||
